Long-term remission of pulmonary veno-occlusive disease associated with primary Sjögren's syndrome following immunosuppressive therapy.
Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement.
Pulmonary manifestations of childhood-onset primary Sjogren's syndrome (SS) masquerading as reactive airways disease in a male patient and review of interstitial lung disease associated with SS.
Management of interstitial lung disease associated with connective tissue disease.
Mathai SC, Danoff SK.
BMJ. 2016 Feb 24;352:h6819. doi: 10.1136/bmj.h6819.
Interstitial lung disease in Sjogren's syndrome: a clinical review.
Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A.
Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):291-300. Epub 2020 Oct 23.
Pulmonary arterial hypertension associated with primary Sjogren's syndrome: a multicentre cohort study from China.
Wang J, Li M, Wang Q, Zhang X, Qian J, Zhao J, Xu D, Tian Z, Wei W, Zuo X, Zhang M, Zhu P, Ye S, Zhang W, Zheng Y, Qi W, Li Y, Zhang Z, Ding F, Gu J, Liu Y, Wang Y, Zhao Y, Zeng X.
Eur Respir J. 2020 Nov 19;56(5):1902157. doi: 10.1183/13993003.02157-2019. Print 2020 Nov.
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.
Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, Mason J, Sattar N, McMurray JJV, McInnes IB, Khunti K, Cambridge G.
Lancet. 2023 Jun 3;401(10391):1878-1890. doi: 10.1016/S0140-6736(23)00457-9. Epub 2023 May 5.
Pulmonary Arterial Hypertension Associated With Primary Sjogren's Syndrome: An Unusual Association.
Ribeirinho-Soares P, Sousa E, Silva I, Cunha F, Almeida J.
Eur J Case Rep Intern Med. 2022 Nov 10;9(11):003606. doi: 10.12890/2022_003606. eCollection 2022.
Biomarkers of interstitial lung disease associated with primary Sjogren's syndrome.
Weng L, Chen Y, Liang T, Lin Y, Liu D, Yu C, Hu Y, Lui W, Liu Y, Chen X, Li Q, Ge S, Ascherman DP, Chen J.
Eur J Med Res. 2022 Oct 10;27(1):199. doi: 10.1186/s40001-022-00828-3.
Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjogren's.
Lee AS, Scofield RH, Hammitt KM, Gupta N, Thomas DE, Moua T, Ussavarungsi K, St Clair EW, Meehan R, Dunleavy K, Makara M, Carsons SE, Carteron NL; Consensus Expert Panel (CEP) Members.
Chest. 2021 Feb;159(2):683-698. doi: 10.1016/j.chest.2020.10.011. Epub 2020 Oct 16.
Pulmonary manifestations of childhood-onset primary Sjogren's syndrome (SS) masquerading as reactive airways disease in a male patient and review of interstitial lung disease associated with SS.
Bartholomeo A, Aujla S, Eklund M, Kerrigan C, Riemer E, Gilbert M.
Pediatr Rheumatol Online J. 2022 Nov 16;20(1):101. doi: 10.1186/s12969-022-00761-z.
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease.
Mulcaire-Jones E, Pugashetti JV, Oldham JM, Khanna D.
Semin Respir Crit Care Med. 2024 Jun;45(3):435-448. doi: 10.1055/s-0044-1786155. Epub 2024 May 13.
Factors Associated With Disease Damage in Puerto Ricans With Primary Sjogren Syndrome.
Jordán-González P, Gago-Piñero R, Vázquez-Sanabria I, Pérez-Ríos N, Vilá LM.
J Clin Rheumatol. 2020 Oct;26(7S Suppl 2):S101-S105. doi: 10.1097/RHU.0000000000001023.
